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Background
Stroke trial outcomes are usually classified in ordered
functional categories, e.g. the modified Rankin Scale
(mRS). Using a single cut-off to distinguish “good” and
“poor” outcome is statistically inefficient and could miss
effects in subgroups where few patients can be expected
to achieve good outcome. “Ordinal shift analysis”, using
ordinal logistic regression to estimate a common odds
ratio for all possible outcome category thresholds, is
more efficient but could still obscure clinically impor-
tant differences in response among prognostic sub-
groups. An alternative “prognosis based outcome” (PBO)
approach defines separate, clinically meaningful good
and poor outcome thresholds (GOTs and POTs) within
each prognostic stratum. The strata are then combined
in an overall trichotomous comparison of “good”/“inter-
mediate”/“poor” outcomes.
Methods
We defined prognostic categories, based on initial neu-
rological scores, and derived suitable GOTs and POTs
for the mRS, using data from a hospital stroke register.
We then validated these thresholds using baseline and
outcome data from the Scandinavian Candesartan Acute
Stroke Trial (SCAST). Finally we performed trichoto-
mous PBO analysis on the SCAST data.
Results
PBO analysis confirmed the overall neutral results of
SCAST but did identify a notable negative treatment
effect within the good prognosis group.
Conclusions
This subgroup effect was not predicted, so requires inde-
pendent confirmation. The PBO approach is clinically
intuitive, can be used to analyse treatment response
within different prognostic groups (as in cancer staging
systems), and is statistically efficient. Also, it does not
require multivariable modelling, making it easier to com-
bine data from different studies in individual patient data
meta-analysis.
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